Dr Hari Iyer, our Principal investigator, traveled to Kentucky to present new findings from the REPEL (Research on the Epidemiology of Prostate Cancer and Environmental Levels) study at the Environmental … Read More
On Tuesday, November 17, 2025, members from the REPEL team joined colleagues from across Rutgers at the annual Cancer Prevention and Control (CPC) Program Conference, held in person at the … Read More
We are pleased to share updates from our expanding portfolio of international research capacity–building initiatives. This year, the team helped design and lead a six-day geospatial cancer research training program … Read More
On November 21, 2025, we hosted a webinar to share the latest updates from the REPEL (Research on the Epidemiology of Prostate Cancer and Environmental Levels) study. The event brought … Read More
Our team contributed to a new cross-sectional analysis of more than 3,100 U.S. counties, which examined how breast, cervical, and colorectal cancer screening rates have changed over the past two … Read More
The Research on the Epidemiology of Prostate Cancer and Environmental Levels (REPEL) study at Rutgers Cancer Institute is making steady progress! As of this month, 95 people have joined the … Read More
The Pre2 CaP Lab is getting ready for another busy year! Some research and publication highlights from the past few months: Agent Orange and Prostate Cancer in Veterans Dr. Iyer … Read More
As part of the Research on the Epidemiology of Prostate Cancer and Environmental Levels (REPEL) study, research coordinator Chidinma Opara filmed and edited a video showing participants how to collect … Read More
This semester, Julianne Varga contributed to the creation of the Precision Prevention of Prostate Cancer Podcast. This first-ever episode delves into the history of PFAS (per- and polyfluoroalkyl substances), examining … Read More
Prostate-specific antigen (PSA) screening for prostate cancer remains controversial due to lack of consistent survival benefits reported from clinical trials, and concerns about harms associated with overtreatment. However, it is … Read More